Clinical Trial: Efficacy and Safety of MitoQ in Improving Cancer Cachexia

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07836777) titled 'Efficacy and Safety of MitoQ in Improving Cancer Cachexia' on Aug. 14.

Brief Summary: Muscle strength was evaluated in subjects with malignant solid tumors and cachexia after 12 weeks of oral MitoQ treatment.

Study Start Date: Oct. 10

Study Type: INTERVENTIONAL

Condition: Cancer Cachexia (CC) Cancer Patients With Solid Tumors

Intervention: DIETARY_SUPPLEMENT: MitoQ (mitoquinol mesylate)

MitoQ 20 mg/day (one 20 mg capsule), administered orally once daily in the morning on an empty stomach.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: The First Affiliated Hospital of Xinxiang Medical College

Information provided by (Resp...